FDA PH Issues Guidelines on the Publishing of Package Insert and Patient Information Leaflet of Registered Drug Products in the Food and Drug Administration (FDA) Verification Portal System

Guidelines: A. Approved PI and PIL of all registered drug products shall be published by the FDA in the Verification …

read more...

Philippines FDA Publishes Circular on The Abridged Processing of Medical Devices Registration With Approval by The NRA of Any ASEAN Member Country

Philippines FDA issues Circular No. 2022-008 on 27th September 2022, aims to provide guidelines on the abridged processing of applications …

read more...

Philippines FDA Publishes Circular on Labelling Requirements of Drug Products under Maximum Retail Price

The Philippines Food and Drug Administration (FDA) has issued FDA Circular No. 2022-005, which provides some information on the process …

read more...

Philippines FDA Publishes Circular on Abridged and Verification Review Pathways

The Philippines Food and Drug Administration (FDA) has issued FDA Circular No. 2022-004, which provides insight on the facilitated registration …

read more...

Philippines FDA Updates Circular on Transition Period for Certificate of Medical Device Notification

The Philippines Food and Drug Administration (FDA) has issued FDA Circular No. 2021-002-B, an amended version of Circular No. 2021-002-A. …

read more...

Philippines FDA Publishes Update on Transfer or Refund of Payments 

The Philippines Food and Drug Administration (FDA) has issued FDA Circular No. 2021-027, which is the revised guidelines for the …

read more...

Philippines FDA Publishes Advisory on Abridged Route for ASEAN-Registered Medical Devices

The Philippines Food and Drug Administration (FDA) has issued Advisory No. 2021-3084, with details regarding the abridged route for the registration of medical devices …

read more...

Philippines FDA Issues Circular on Revised Post-Marketing Surveillance Requirements for New Drugs under Monitored Release

The Philippines Food and Drug Administration (FDA) has issued Circular No. 2021-020 to provide updated post-marketing surveillance (PMS) requirements for new drugs under monitored release, …

read more...

Philippines FDA Issues Circular on the Reference List of Class A Medical Devices

The Philippines Food and Drug Administration (FDA) has issued Circular No. 2021-017 on the 16th of August 2021, to guide manufacturers, importers, distributors, and other stakeholders in the medical device industry regarding the list …

read more...

More News